SE3D
Develops desktop 3D bioprinters and educational courseware for K-14 science education, enabling hands-on learning in tissue engineering and biomedical sciences.
- CEO / Founder
- Prashanth Asuri
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- Grant
- Key Investors
- National Science Foundation
Technology & Products
Key Products
r3bEL desktop bioprinter; Science education courseware modules; Bioprinting curriculum for K-14
Technological Advantage
Proprietary extrusion-based bioprinting technology optimized for classroom safety and simplicity, protected by NSF SBIR grants (Phase I and II) with educational content moat through curriculum development
Differentiation
Value Proposition
Provides affordable, classroom-friendly bioprinting systems with integrated curriculum to democratize access to advanced biomedical technology, reducing equipment costs by 80% compared to research-grade bioprinters while meeting educational standards.
How They Differentiate
Focuses exclusively on educational market with complete curriculum integration, while competitors target research labs with higher-cost systems; r3bEL printer costs ~$5,000 vs. $10,000+ for research bioprinters
Market & Competition
Target Customers
K-14 schools, educational institutions, science teachers, students
Industry Verticals
Education; EdTech; Biotechnology Education
Competitors
CELLINK (now BICO); Allevi; RegenHU
Growth & Milestones
Growth Metrics
The SE3D annual revenue was $5.7 million in 2025.
Major Milestones
2014: Company founded; 2015-2018: Received NSF SBIR Phase I and II grants; 2017: Demoed technology at CES; Development of r3bEL desktop bioprinter
Notable Customers
Winchester Thurston High School; Various K-14 schools implementing bioprinting curriculum